NIH-funded research R01 grant

Fungal–bacterial gut and bloodstream infections: how mixed infections worsen outcomes

Official title: Fungal-bacterial dynamics driving dysregulated host responses and lethal synergism

Funded at University of Tennessee Health Sci Ctr · NIH-11377678 · Data updated 2026-11-12

A funded project will study how fungal and bacterial infections together worsen illness in hospitalized patients and why they lead to higher death rates.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Tennessee Health Sci Ctr
NIH-funded
Lab location1 site (Memphis, United States)
Project startJuly 15, 2024
Project endJune 30, 2029
Funding year2026
Award (this year)$777,079
NIH project number5R01AI177615-03
Project IDNIH-11377678 on NIH RePORTER

Who could benefit from this research

Could help

Patients with abdominal infections involving both fungal and bacterial pathogens or at risk for these polymicrobial infections could benefit from future applications of this research.

Less likely to help

Patients with infections caused by a single organism or unrelated conditions may not benefit from this study’s findings.

What this research studies

This grant aims to understand why infections caused by Candida albicans and bacteria together cause worse outcomes in abdominal infections. Researchers will look at how microbes interact to increase toxin production and trigger harmful immune and blood-clotting responses. They will use animal models and human-relevant experiments to map the steps from coinfection to severe disease, with the goal of identifying points to intervene. The work focuses on mechanisms that could someday guide better treatments for patients with polymicrobial abdominal infections.

Why it matters

Potential benefit: If successful, the findings could lead to targeted therapies that reduce mortality and complications in patients with polymicrobial abdominal infections.

How similar studies have gone: Previous work shows that microbial interactions can worsen disease, but this project investigates specific fungal–bacterial cooperation in abdominal infections, which is less well understood and considered innovative.

Where this research is happening

  • University of Tennessee Health Sci Ctr
    Memphis, United States
    Active

Researchers

  • Principal investigator: Peters, Brian M — University of Tennessee Health Sci Ctr
  • Study coordinator: Peters, Brian M

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.